TrinityPoint Wealth LLC bought a new stake in shares of MetLife, Inc. (NYSE:MET – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,870 shares of the financial services provider’s stock, valued at approximately $237,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. MeadowBrook Investment Advisors LLC boosted its holdings in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the period. Carmichael Hill & Associates Inc. lifted its holdings in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC boosted its position in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares in the last quarter. Peterson Financial Group Inc. bought a new stake in MetLife during the third quarter worth about $30,000. Finally, Fortitude Family Office LLC increased its holdings in shares of MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after buying an additional 266 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.
MetLife Price Performance
Shares of MET opened at $83.37 on Tuesday. The stock has a market cap of $57.73 billion, a P/E ratio of 16.81, a price-to-earnings-growth ratio of 0.76 and a beta of 1.05. MetLife, Inc. has a 1 year low of $61.85 and a 1 year high of $86.94. The stock’s 50-day moving average price is $81.76 and its two-hundred day moving average price is $75.71. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
Analyst Upgrades and Downgrades
MET has been the topic of several recent analyst reports. Barclays reduced their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. Piper Sandler upped their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Bank of America lowered their price target on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a report on Thursday, August 1st. StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th. Finally, TD Cowen assumed coverage on MetLife in a research note on Wednesday, October 9th. They issued a “buy” rating and a $97.00 target price for the company. Fourteen research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $88.46.
Check Out Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- P/E Ratio Calculation: How to Assess Stocks
- Applied Materials Market Capitulates: Now is the Time to Buy
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.